Skip to main content

Table 7 Reported adjusted unstandardized mean differences, standardized effect sizes, and p-values (between groups) in studies measuring QoL

From: Interprofessional collaboration and patient-reported outcomes in inpatient care: a systematic review

Source (Study type)

Study population

Outcome measures QoL (total score)

Adjusted mean differences (95% CI or SE)

Standardized effect sizes

p-value

Boesen et al. 2018 [14] (RCT)

Multiple sclerosis

FAMS (0–176)

1.6 (−1.4, 4.7)*

 

0.232

MSIS-29

Physical (0–1001)‡

−0.6 (−3.0, 1.8)*

 

0.640

Psychological (0–100)‡

−2.7 (−5.6, −0.1)*

 

0.046

EQ-5D-5L (−0.624 to −1.000)

0.006 (−0.015, 0.028)*

 

0.596

EQ VAS (0–100)

2.5 (−1.1, 5.9)*

 

0.112

15D questionnaire (0.106–1.000)

0.017 (0.005, 0.030)*

 

0.008

Gade et al. 2008 [16] (RCT)

Palliative care

MCOHPQ

Physical area (0–10)‡

  

0.91

Emotional/relationship area (0–10)‡

  

0.07

Spiritual area (0–10)

  

0.55

Quality of life (0–10)

  

0.78

Goldberg et al. 2013 [17] (RCT)

Cognitive impairment in old age (> 65)

EQ-5D

Self-completed (0–1)‡

0.00 (−0.09, 0.09)

 

0.96

Proxy completed (0–1)‡

−0.07 (−0.15, 0.00)

 

0.06

DEMQOL

Self-completed (0–108)

0.7 (−2.8, 4.1)

 

0.70

Proxy completed (0–124)

−0.4 (−4.6, 3.8)

 

0.84

Grudzen et al. 2016 [20] (RCT)

Palliative care for patients with advanced cancer

FACT-G (0–108)

  

0.054

Hewett et al. 2016 [22] (RCT)

Homelessness

EQ-5D-5L (.)

0.09 (−0.03, 0.22)

 

0.151

Mangels et al. 2009 [23] (RCT)

Chronic low back pain

LSQ-G (7–49)

  

NS

SF-12

Physical health status (.)

   

Mental health status (.)

   

Monticone et al. 2015 [24] (RCT)

Parkinson’s disease

I-PDQ-39

Mobility (0–100)‡

−14.1 (3.4)*

  

Activities of daily living (0–100)‡

−19.6 (2.2)*

  

Emotional well-being (0–100)‡

−14.8 (2.9)*

  

Stigma (0–100)‡

−14.9 (3.4)*

  

Social support (0–100)‡

−10.2 (3.4)*

  

Cognition (0–100)‡

−10.4 (2.6)*

  

Communication (0–100)‡

−8.4 (4.8)*

  

Bodily discomfort (0–100)‡

−12.2 (2.8)*

  

Sidebottom et al. 2015 [26] (RCT)

Palliative care for patients with acute heart failure

MLHF (0–105)

4.92 (4.61, 5.23)

 

0.000

Wu et al. 2019 [28] (RCT)

Critical care survivors

AQoL-4D (0–1)

   

SF-12

Physical health status (.)

Mental health status (.)

   

Angst et al. 2009 [30] (NRS)

Chronic pain

SF-36

Physical functioning (0–100)

 

0.06 (Hedges’ g)

0.361

Social functioning (0–100)

 

0.32 (Hedges’ g)

0.076

Brédart et al. 2009 [31] (NRS)

Cancer

EORTC QLQ-C30

 

Physical functioning (.)

  

NS

 

Role functioning (.)

  

NS

 

Emotional functioning (.)

  

NS

 

Social functioning (.)

  

NS

 

Overall health status (.)

  

NS

Marcussen et al. 2020 [34] (NRS)

Severe mental illness

SF-36

Physical functioning (0–100)

Mental functioning (0–100)

0.40 (−2.3, 1.24)

5.30 (2.71, 7.89)

 

0.6

0.001

Semrau et al. 2015 [33] (NRS)

Chronic low back pain

SF-12

Physical health status (0–100)

0.50 (−0.99, 1.99)

0.029 (Cohens’ d)

 

Mental health status (0–100)

0.62 (−1.35, 2.58)

0.027 (Cohens’ d)

 

Deenik et al. 2018 [35] (CBA)

Severe mental illness

EQ-5D (0–1)

−0.02 (−0.12, 0.08)

 

0.736

WHOQOL-BREF

Physical (1–10)

0.14 (−0.80, 1.09)

 

0.765

Psychological (1–10)

−0.37 (-1.38, 0.63)

 

0.465

Social (1–10)

0.63 (−0.47, 1.73)

 

0.257

Environmental (1–10)

0.42 (−0.97, 1.80)

 

0.537

  1. Estimates of adjusted mean differences, standardized effect sizes, or p-values refer to tests for difference in means between treatment and control groups at the time of follow-up (t1) or to the difference in change scores (t0–t1) between groups.(.) Not reported; *unadjusted, ‡inverted scale (lower score indicates greater impact); AQoL-4D, assessment of quality of life, DEMQOL dementia quality of life measure, EORTC QLQ-30 EORTC Quality of Life with Cancer Questionnaire, EQ-5D (-5L) EuroQol 5D (-5L, long version), EQ VAS EuroQol visual analogue scale, ES effect size, FACT-G Functional Assessment of Cancer Therapy — General measure, FAMS functional assessment of multiple sclerosis questionnaire, I-PDQ-39 Italian 39-question Parkinson’s disease questionnaire, LSQ-G German Life Satisfaction Questionnaire (Fragebogen zur Lebenszufriedenheit), MCOHPQ Modified City of Hope QoL Patient Questionnaire, MLHF Minnesota Living with Heart Failure questionnaire, MSIS-29 Multiple Sclerosis Impact Scale-29 version 2, NA not applicable, NS not significant, no further details reported, QoL quality of life, SE standard error, SF-12 Short Form 12, SF-36 Short Form 36, WHOQOL-BREF World Health Organization Quality of Life Assessment scale